Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has won approval for the IV formulation of generic Acetazolamide Sodium, enhancing the f...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
PH HEALTH has attained FDA approval under ANDA203573, a milestone finalized on December 18 that is anticipated to drive commercial growth and solidify...
# FDA Approves Fonseca Biosciences' XTORO for Ear Infections The FDA has approved Fonseca Biosciences' XTORO (finafloxacin), an otic fluoroquinolone ...
Epic Pharma, LLC received FDA approval for its Abbreviated New Drug Application covering oral Oxymorphone Hydrochloride tablets, positioning the compa...
Teva Pharmaceuticals USA has received approval for Nifedipine Extended-Release, a decision expected to intensify generic competition in the cardiovasc...
JUBILANT CADISTA received FDA approval for an ANDA product, potentially expanding its generic portfolio and generating meaningful market revenue. This...
Ascend Laboratories, LLC received final approval on November 14, 2014, for its Abbreviated New Drug Application (ANDA) 203005 for Mycophenolate Mofeti...
Prasco Laboratories has secured FDA approval for dapagliflozin and metformin hydrochloride, a generic formulation that will likely become a cost-effec...
Mylan Pharmaceuticals Inc. secured the 2014 approval of ANDA 205651 for the oral formulation of Nevirapine, potentially increasing generic accessibili...
# FDA Approves Eli Lilly's Trulicity for Type 2 Diabetes Treatment Eli Lilly and Company received FDA approval for Trulicity (dulaglutide), a once-we...
TEVA PHARMS USA announced Tuesday it had received FDA approval for its generic version of this drug, setting the stage to compete in the niche market....
Merck Sharp & Dohme LLC secured FDA approval for pembrolizumab injection in 2014, launching the blockbuster Keytruda therapy that has since reshaped t...
Rhodes Pharmaceuticals announced on August 28, 2014, that it received FDA approval for ANDA 201278, launching a generic version of the potent opioid c...
Zydus Lifesciences Limited announced the FDA approval of generic metformin hydrochloride tablets (ANDA 203686), a strategic move that is expected to b...
On August 19, 2014, Apotex Corp received FDA approval for Mycophenolic Acid, a generic version of Mycophenolate Sodium tablets, signaling a shift in t...
Macleods Pharmaceuticals has received approval from the U.S. Food and Drug Administration for its abbreviated new drug application, #ANDA202862, to ma...
On August 8, Rising received final approval for its ANDA090943, positioning the company to compete in the market for the undisclosed substance. This a...
Janssen Pharmaceuticals, Inc. announced the approval of INVOKAMET (canagliflozin and metformin hydrochloride) for oral use on August 8, 2014, creating...
# FDA Approves Rising Pharmaceuticals' Generic Drug Application Rising Pharmaceuticals received FDA approval for an abbreviated new drug application ...
Torrent Pharmaceuticals announced the approval of the ANDA for a certain generic drug, marking a strategic entry into this market segment. This regula...